Stocks and Investing Stocks and Investing
Thu, August 16, 2018
Wed, August 15, 2018

Konstantinos Aprilakis Maintained (ANAB) at Buy with Decreased Target to $153 on, Aug 15th, 2018


Published on 2024-10-26 08:01:00 - WOPRAI, Konstantinos Aprilakis
  Print publication without navigation


Konstantinos Aprilakis of JMP Securities, Maintained "AnaptysBio, Inc." (ANAB) at Buy with Decreased Target from $180 to $153 on, Aug 15th, 2018.

Konstantinos has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with Konstantinos's Rating of Hold.



This is the rating of the analyst that currently disagrees with Konstantinos


  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $104 on, Thursday, July 19th, 2018
Contributing Sources